22nd Century Group (XXII) Releases Quarterly Earnings Results

22nd Century Group (NYSEAMERICAN:XXII) released its quarterly earnings results on Wednesday. The biotechnology company reported $0.04 earnings per share (EPS) for the quarter, MarketWatch Earnings reports. The business had revenue of $6.26 million for the quarter.

Shares of XXII stock traded down $0.10 during trading hours on Thursday, hitting $2.57. 76,759 shares of the company’s stock traded hands, compared to its average volume of 2,485,598. 22nd Century Group has a 12 month low of $1.92 and a 12 month high of $4.44.

Separately, Zacks Investment Research downgraded shares of 22nd Century Group from a “hold” rating to a “sell” rating in a research note on Thursday, August 16th.

An institutional investor recently raised its position in 22nd Century Group stock. Bank of New York Mellon Corp grew its holdings in shares of 22nd Century Group Inc (NYSEAMERICAN:XXII) by 200.5% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 337,281 shares of the biotechnology company’s stock after acquiring an additional 225,039 shares during the period. Bank of New York Mellon Corp owned about 0.27% of 22nd Century Group worth $830,000 as of its most recent SEC filing.

TRADEMARK VIOLATION WARNING: “22nd Century Group (XXII) Releases Quarterly Earnings Results” was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://sportsperspectives.com/2018/11/08/22nd-century-group-xxii-releases-quarterly-earnings-results.html.

22nd Century Group Company Profile

22nd Century Group, Inc, a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies.

Further Reading: Does the discount rate affect the economy?

Earnings History for 22nd Century Group (NYSEAMERICAN:XXII)

Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply